专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06171520B2 Reagents for labeling SH groups, process for the preparation of them and method for labeling with them 失效
标题翻译：用于标记SH组的试剂，制备它们的方法和用它们标记的方法
公开(公告)号：US06171520B2
公开(公告)日：2001-01-09
申请号：US08945885
申请日：1997-11-14
申请人： Kazuhiro Imai , Hiromichi Eto , Takeshi Kotsugai , Tadashi Narita
发明人： Kazuhiro Imai , Hiromichi Eto , Takeshi Kotsugai , Tadashi Narita
IPC分类号： C09K1107
CPC分类号： C07D401/12 , G01N33/533
摘要： Disclosed are SH-labeling reagents containing acridine compounds represented by the following formula (I): wherein A represents the following group: —(CH2)m1— or —(CH2)m2—Q—(CH2)n— in which Q represents a group —S+RX−—, a group —N+RR1X−— wherein R1 represents an alkyl group having 1 to 6 carbon atoms or an aryl group, a group wherein R2 and R3 may be the same or different and are each independently a group —(CH2)k— (k: a number of 1 to 3) or —O(CH2CH2O)l— (l: a number of 1 to 3), m1 stands for a number of 1 to 6, m2 denotes a number of 0 to 2, n means a number of 1 to 2; R represents an alkyl group having 1 to 6 carbon atoms or an aryl group; and X− represents an anion, or intermediates thereof; preparation processes of the acridine compounds; and methods for labeling analytes by using the compounds.
摘要翻译：公开了含有下式（I）表示的吖啶化合物的SH-标记试剂：其中A表示以下基团：Q表示-S + RX-的基团，-N + RR1X--基团，其中R1表示烷基具有1至6个碳原子的基团或芳基，其中R2和R3中的基团可以相同或不同，并且各自独立地为基团 - （CH 2）k - （k：1至3的数）或-O（CH 2 CH 2 O ）1-（1：1〜3的数），m1表示1〜6的数，m2表示0〜2的数，n表示1〜2的数; R表示1〜 6个碳原子或芳基; 和X-表示阴离子或其中间体; 吖啶化合物的制备方法; 以及通过使用化合物标记分析物的方法。

2. 发明授权

US6008239A Triazole derivative or salt thereof 失效
标题翻译：三唑衍生物或其盐
公开(公告)号：US6008239A
公开(公告)日：1999-12-28
申请号：US135163
申请日：1998-08-17
申请人： Yasushi Kaneko , Sunao Takeda , Minoru Tokizawa , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato
发明人： Yasushi Kaneko , Sunao Takeda , Minoru Tokizawa , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato
IPC分类号： A01N43/653 , C07D249/08 , C07D521/00 , A61K31/505
CPC分类号： C07D231/12 , A01N43/653 , C07D233/56 , C07D249/08
摘要： Described is a triazole derivative represented by the formula (1): ##STR1## wherein R.sup.1 represents a lower alkyl group or an aralkyl group, R.sup.2 represents a hydrogen atom, a lower alkyl group, an aralkyl group or an acyl group, X.sup.1 and X.sup.2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a trifluoromethyl group, n stands for an integer of 0 to 2 and m stands for an integer of 1 to 5, or salt thereof; and also a pharmaceutical comprising the derivative or salt thereof as an effective ingredient. The compound as described above has a high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.
摘要翻译：描述了由式（1）表示的三唑衍生物：其中R1表示低级烷基或芳烷基，R2表示氢原子，低级烷基，芳烷基或酰基，X1和X2相同或不同，各自独立地表示氢原子，卤素原子或三氟甲基，n表示0〜2的整数，m表示1〜5的整数，或其盐。以及包含其衍生物或其盐作为有效成分的药物。如上所述的化合物具有高的抗真菌活性，并且可用于预防和治疗哺乳动物真菌感染。

3. 发明授权

US06172266B2 Triazole derivative or slat thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient 失效
标题翻译：三唑衍生物或其盐，其制备方法和含有所述化合物作为有效成分的药物
公开(公告)号：US06172266B2
公开(公告)日：2001-01-09
申请号：US09471286
申请日：1999-12-23
申请人： Sunao Takeda , Yasushi Kaneko , Minoru Tokizawa , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato
发明人： Sunao Takeda , Yasushi Kaneko , Minoru Tokizawa , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato
IPC分类号： C07C32307
CPC分类号： C07D231/12 , C07C323/22 , C07C2601/02 , C07D233/56 , C07D249/08 , C07D303/34
摘要： Described is a triazole derivative represented by the formula (1): wherein R1 represents a hydrogen atom, a lower alkyl group or an aralkyl group, X1 and X2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a halogenoalkyl and n stands for an integer of 0 to 2, or salt thereof; a preparation process of said compound and a pharmaceutical comprising said compound as an effective ingredient. The compound as described above has high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.
摘要翻译：描述了由式（1）表示的三唑衍生物：其中R1表示氢原子，低级烷基或芳烷基，X1和X2相同或不同，并且各自独立地表示氢原子，卤素原子或卤代烷基，n表示0〜2的整数，或其盐; 所述化合物的制备方法和包含所述化合物作为有效成分的药物。如上所述的化合物具有高抗真菌活性，并且可用于预防和治疗哺乳动物真菌感染。

4. 发明授权

US5939448A Triazole derivative or salt thereof 失效
标题翻译：三唑衍生物或其盐
公开(公告)号：US5939448A
公开(公告)日：1999-08-17
申请号：US872159
申请日：1997-06-10
申请人： Minoru Tokizawa , Sunao Takeda , Yasushi Kaneko , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato , Hideaki Matsuda
发明人： Minoru Tokizawa , Sunao Takeda , Yasushi Kaneko , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato , Hideaki Matsuda
IPC分类号： C07D249/08 , C07D303/34 , C07D521/00 , A61K31/41
CPC分类号： C07D231/12 , C07D233/56 , C07D249/08 , C07D303/34
摘要： Described is a triazole derivative represented by the formula (1): wherein R represents a hydrogen atom, an alkyl group, an aralkyl group or an acyl group, n stands for 0 to 2 and m stands for 1 to 5 or salt thereof, and a pharmaceutical containing the derivative or salt as an effective ingredient.
摘要翻译：描述了由式（1）表示的三唑衍生物：其中R表示氢原子，烷基，芳烷基或酰基，n表示0至2，m表示1至5或其盐，含有衍生物或盐作为有效成分的药物。

5. 发明授权

US06229049B1 Preparation process of difluoroacetophenone derivative 失效
标题翻译：二氟苯乙酮衍生物的制备方法
公开(公告)号：US06229049B1
公开(公告)日：2001-05-08
申请号：US09488746
申请日：2000-01-21
申请人： Sunao Takeda , Yasushi Kaneko , Hiromichi Eto , Susumu Sato
发明人： Sunao Takeda , Yasushi Kaneko , Hiromichi Eto , Susumu Sato
IPC分类号： C07C31914
CPC分类号： C07C319/20 , C07C323/22
摘要： The invention relates to a process for preparing a difluoroacetophenone derivative (4) by alkylthionating a compound (1) into a compound (2) and reacting this compound with a compound (3). wherein X1 is Cl, Br or I, X2 and X3 are independently a halogen atom, H or perfluoroalkyl group, X4 is a halogen atom, R1 is an alkyl, aryl or aralkyl group, and R2 is methyl, ethyl or cyclopropyl group.
摘要翻译：本发明涉及通过将化合物（1）烷基化成化合物（2）并使该化合物与化合物（3）反应制备二氟苯乙酮衍生物（4）的方法，其中X1为Cl，Br或I，X2和X3 独立地为卤素原子，H或全氟烷基，X4为卤素原子，R1为烷基，芳基或芳烷基，R2为甲基，乙基或环丙基。

6. 发明授权

US06204415B1 Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient 失效
公开(公告)号：US06204415B1
公开(公告)日：2001-03-20
申请号：US09551567
申请日：2000-04-18
申请人： Sunao Takeda , Yasushi Kaneko , Minoru Tokizawa , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato
发明人： Sunao Takeda , Yasushi Kaneko , Minoru Tokizawa , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato
IPC分类号： C07C32307
CPC分类号： C07D231/12 , C07D233/56 , C07D249/08 , C07D303/48
摘要： Described is a triazole derivative represented by the formula (1): wherein R1 represents a hydrogen atom, a lower alkyl group or an aralkyl group, X1 and X2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a halogenoalkyl and n stands for an integer of 0 to 2, or salt thereof; a preparation process of said compound and a pharmaceutical comprising said compound as an effective ingredient. The compound as described above has high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.

7. 发明授权

US6002028A Triazole derivative, preparation process thereof and pharmaceutical comprising the same as an effective ingredient 失效
公开(公告)号：US6002028A
公开(公告)日：1999-12-14
申请号：US311058
申请日：1999-05-14
申请人： Minoru Tokizawa , Sunao Takeda , Yasushi Kaneko , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato , Hideaki Matsuda
发明人： Minoru Tokizawa , Sunao Takeda , Yasushi Kaneko , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato , Hideaki Matsuda
IPC分类号： C07D303/34 , C07D521/00
CPC分类号： C07D231/12 , C07D233/56 , C07D249/08 , C07D303/34
摘要： Described is a triazole derivative represented by the formula (1) or salt thereof, preparation process thereof, preparation intermediates represented by the formulas (2) and (3), and a pharmaceutical comprising the compound represented by the formula (1) or salt thereof. ##STR1## wherein n stands for 0, 1 or 2, X.sup.1 represents H or F and Y.sup.1 and Y.sup.2 each independently represents H, halogen or CF.sub.3.

8. 发明授权

US06737434B2 Imidazole derivatives or their salts 失效
标题翻译：咪唑衍生物或其盐
公开(公告)号：US06737434B2
公开(公告)日：2004-05-18
申请号：US10380828
申请日：2003-03-19
申请人： Minoru Tokizawa , Sunao Takeda , Yasushi Kaneko , Koji Kusano , Hiromichi Eto , Koichi Tachibana , Susumu Sato , Tadayoshi Taniyama
发明人： Minoru Tokizawa , Sunao Takeda , Yasushi Kaneko , Koji Kusano , Hiromichi Eto , Koichi Tachibana , Susumu Sato , Tadayoshi Taniyama
IPC分类号： C07D23360
CPC分类号： C07D233/64 , C07D231/12 , C07D233/56 , C07D249/08
摘要： Imidazole derivatives of the formula (1) or salts thereof, pharmaceuticals containing the derivatives or the salts, and intermediates for the synthesis of the derivatives or the salts (wherein R1 is lower alkyl; R2 is alkyl or aralkyl; and X1 is halogeno). These compounds exhibit G-CSF-like activities and can be substituted for G-CSF preparations.
摘要翻译：式（1）的咪唑衍生物或其盐，含有衍生物或盐的药物，以及用于合成衍生物或盐的中间体（其中R 1为低级烷基; R 2为烷基或芳烷基; X 1为卤素）。这些化合物表现出G-CSF样活性，可代替G-CSF制剂。

9. 发明授权

US06194592B1 Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient 失效
公开(公告)号：US06194592B1
公开(公告)日：2001-02-27
申请号：US09551569
申请日：2000-04-18
申请人： Sunao Takeda , Yasushi Kaneko , Minoru Tokizawa , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato
发明人： Sunao Takeda , Yasushi Kaneko , Minoru Tokizawa , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato
IPC分类号： C07D30334
CPC分类号： C07D231/12 , C07D233/56 , C07D249/08 , C07D303/48
摘要： Described is a triazole derivative represented by the formula (1): wherein R1 represents a hydrogen atom, a lower alkyl group or an aralkyl group, X1 and X2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a halogenoalkyl and n stands for an integer of 0 to 2, or salt thereof; a preparation process of said compound and a pharmaceutical comprising said compound as an effective ingredient. The compound as described above has high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.

10. 发明授权

US06184396B2 Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient 失效
公开(公告)号：US06184396B2
公开(公告)日：2001-02-06
申请号：US09551854
申请日：2000-04-18
申请人： Sunao Takeda , Yasushi Kaneko , Minoru Tokizawa , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato
发明人： Sunao Takeda , Yasushi Kaneko , Minoru Tokizawa , Hiromichi Eto , Kazuya Ishida , Kazunori Maebashi , Masaru Matsumoto , Takemitsu Asaoka , Susumu Sato
IPC分类号： C07D30334
CPC分类号： C07D231/12 , C07C323/22 , C07C2601/02 , C07D233/56 , C07D249/08 , C07D303/34
摘要： Described is a triazole derivative represented by the formula (1): wherein R1 represents a hydrogen atom, a lower alkyl group or an aralkyl group, X1 and X2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a halogenoalkyl and n stands for an integer of 0 to 2, or salt thereof; a preparation process of said compound and a pharmaceutical comprising said compound as an effective ingredient. The compound as described above has high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式